Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Prestigious National Fellowship Awarded To University Of Miami Nurse To Improve Health Care
A national fellowship program focused on expanding the role of nurses to lead change in the U.S. health care system has been awarded to Elias Provencio-Vasquez, Ph.D., N.P., F.A.A.N., F.A.A.N.P., associate professor at the University of Miami (UM) School of Nursing and Health Studies. He is one of twenty nurses selected nationwide as a 2009 Robert Wood Johnson Foundation® (RWJF) Executive Nurse Fellow.

Important Questions Raised About Genetic Research Based Only On Blood Samples; New Treatment In Vascular Disease Foreseen At The Same Time
Research by a group of Montreal scientists calls into question one of the most basic assumptions of human genetics: that when it comes to DNA, every cell in the body is essentially identical to every other cell. Their results appear in the July issue of the journal Human Mutation.
News of the day
Survey Reveals Public's Concerns About Prescription Medication Overdose Risks Following Death Of Michael Jackson
Survey results released by The American Society of Health-System Pharmacists (ASHP) revealed the effects of publicity around Michael Jackson"s alleged prescription drug misuse. More than 200 pharmacists who work in home, ambulatory, and chronic care practices responded to the survey conducted on July 1, 2009.
Nutrition

Hebrew University Research Leads To Advanced Trials Of New Cancer Treatment

Research by a Hebrew University of Jerusalem professor has led to the development of a product that has been shown in clinical trials to be successful in halting the growth of various types of cancer cells. The research, conducted by Prof. Avraham Hochberg of the Silberman Institute of Life Sciences at the university, has won for him first prize among faculty members for this year"s Kaye Innovations Awards, which was presented on June 9 during the annual Hebrew University Board of Governors meeting. Prof. Hochberg was successful in isolating the H19 gene in humans and determining that it is significantly expressed in over 33 different forms of cancer, including superficial bladder carcinoma and pancreatic, ovarian and metastatic liver cancer, while laying dormant and non-expressed in non-cancerous cells. Research has also demonstrated that the H19 gene plays a significant role in the tumor development process by enabling tumor cells to survive under stress conditions, such as low serum and low oxygen levels, that are typical conditions of the environment in which cancerous cells develop. This survival supports the growth of the tumor and the development of metastases. The research and understanding of the origin of cancer and metastases has progressed significantly in recent years. In light of scientific breakthroughs in cancer research, and the role of the H19 gene in such processes, it is believed that an anti-cancer drug based on suppressing the expression of the H19 gene has the potential to provide benefits that are competitive with existing treatment methods. Prof. Hochberg"s research was patented by Yissum Research Development Company of the Hebrew University. In 2005 Yissum established BioCancell Inc., to which it licensed the technology. The company is now traded in the Tel Aviv stock exchange (TASE). BioCancell"s leading product, BC-819, has demonstrated efficacy in clinical trials (now in an advanced stage) in Israel and the US for the treatment of human bladder, pancreatic and ovarian cancers. Jerry Barach The Hebrew University of Jerusalem


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009